Empowering patients through data
Driving a new era of diagnostics and precision treatment to improve the lives of patients.
Pathology
Artificial
Intelligence
Guidance
Engine
Mission
Use the incredible power of tissue-based AI to develop and deliver globally, a new generation of digital diagnostics and predictive tests, empowering pathologists and transforming oncology.
Vision
Drive a new era of diagnostics and precision treatment to improve the lives of cancer patients.
About Paige
Using AI to inspire a new future for pathology
Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics. We make it possible not only to provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and confidently, but also to go beyond by extracting novel insights from digital slides that can’t be seen by the naked eye. These unique tissue signatures have the potential to help guide treatment decisions and enable the development of novel biomarkers from tissues for diagnostic, pharmaceutical and life sciences companies.
How we support our mission
Esteemed leadership
- Led by a team of experts in pathology, machine learning and healthcare
Improving traditional pathology
- Software that provides additional information on every slide
- Helps Pathologists work efficiently and confidently
Paving the future of pathology
- Advanced software to extract new information from pathology slides for additional information to create the most informed and personalized patient treatment workflows possible
Commitment to making an impact
- Empowering pathologists and transforming oncology
Values
Paige is A.D.E.P.T. Together we are skilled, accomplished, and proficient in our mission to transform cancer diagnostics.
Accountable
Be accountable to yourself and to others. Own your role.
Disruptive
Don’t settle for mediocrity. Trailblazing in a fast moving market is our business.
Execution-focused
Strategy without execution is just a pipedream. Make it happen.
Patient-centric
Keep the patient and our customer at the heart of everything we do, always.
Trusting
Build trust, be sincere, communicate clearly and team up to win!
Timeline of Paige
Paige was founded 
2017
Data License Deal with MSK
2018
Paige Prostate Detection received FDA
breakthrough designation 
2019
Paige Prostate Detection approved for
use in Europe (CE-Mark)
FullFocus received FDA clearance and CE-
Mark for use in diagnostic practice
Paige Prostate Grading and
Quantification approved for use in
Europe (CE-Mark)
Paige reaches 100 employees
Paige sets up UK Office
Paige Prostate Detection
received FDA approval
Paige wins Phase IV NHSx award for
Paige Prostate Evaluation in NHS 
Medical Innovation Briefing
given by NICE on Paige Prostate 
Paige Breast Lymph Node
Detection CE-MARK
2022
Paige was founded
2017Data License Deal with MSK
2018
Paige Prostate Detection received FDA
breakthrough designation
2019
Paige Prostate Detection approved for
use in Europe (CE-Mark)
FullFocus received FDA clearance and CE-
Mark for use in diagnostic practice
Paige Prostate Grading and
Quantification approved for use in
Europe (CE-Mark)
Paige reaches 100 employees
Paige sets up UK Office
2020
Paige Prostate Detection
received FDA approval
Paige wins Phase IV NHSx award for
Paige Prostate Evaluation in NHS
Medical Innovation Briefing
given by NICE on Paige Prostate
Paige Breast Lymph Node
Detection CE-MARK
2022
Meet our founders
David S. Klimstra, MD
Founder, Chief Scientist
“At Memorial Sloan Kettering, we began the process of digitizing pathology slides in 2008, using the resulting digital images to develop a research program in computation pathology. These resulting AI algorithms demonstrated the potential to transform diagnosis and to develop digital prognostic and predictive biomarkers. We founded Paige in order to bring these research tools to clinical use— to ultimately help transform the practice of pathology.”
Thomas Fuchs, Dr. Sc.
Founder, Chief Scientist
“This is a critical time for Pathology, as pathologists are carrying a heavier workload than ever before. Paige was founded to help address their needs through cutting-edge technologies. Paige represents the future of computational pathology and we believe in empowering pathologists with additional insights from rich images, so they can make more effective, confident diagnoses.”
Investors
